Capsules encapsulating larotrectinib, a kinase inhibitor, delivered by biotech firms to precision oncology practices in comprehensive cancer centers. Obtained by therapeutic committees and distributors for molecularly targeted treatments in advanced diagnostic-equipped facilities.